Responses
Oral Presentations
Abstract session: RA: anti-TNF therapy
OP0068 A Phase 3 Randomised Controlled Trial to Compare CT-P13 with Infliximab in Patients with Active Rheumatoid Arthritis: 54 Week Results from the Planetra Study
Compose a Response to This Article
Other responses
No responses have been published for this article.